Luciferase Reporter Tumor Cell Lines

In order to better evaluate drug anti-tumor activity, it is essential to have a method that can help track tumor growth and quantify tumor burden in vivo easily. Biocytogen has created a list of luciferase-labeled cell lines for tumor model generation and bioluminescence imaging in live animal models, providing simpler, highly sensitive, robust means for tumor measurement and in vivo drug efficacy studies.

Attention

Biocytogen provides engineering service to generate the humanized tumor cell lines from customer’s own cell lines.

Our humanized tumor cell lines are for pharmacology services ONLY.

Luciferase Reporter Tumor Cell Lines

Product Disease Organism Culture Properties
B-CAG-luc 4T1 Breast carcinoma Mus musculus, mouse Adherent
B-CAG-luc B16-F10 Melanoma Mus musculus, mouse Adherent
B-CAG-luc Daudi Burkitt’s lymphoma Homo sapiens, human Suspension
B-CAG-luc EL4 Lymphoma Mus musculus, mouse Suspension
B-CAG-luc Hep 3B (v2) Hepatocellular carcinoma Homo sapiens, human Adherent
B-CAG-luc K-562 Leukemia (CML) Homo sapiens, human Suspension
B-CAG-luc MIA PaCa-2 Pancreatic carcinoma Homo sapiens, human Adherent
B-CAG-luc U87-MG Glioblastoma Homo sapiens, human Adherent
B-Luciferase Hep3B2.1-7 Cell Line Hepatocellular carcinoma Homo sapiens, human Adherent
B-Luciferase Hepa 1-6 Cell Line Hepatoma Mus musculus, mouse Adherent
B-luc-GFP HT-29 Colorectal adenocarcinoma Homo sapiens, human Adherent
B-luc-GFP NCI-H1975 Adenocarcinoma; non­small cell lung cancer Homo sapiens, human Adherent
B-luc-GFP Raji Lymphoma, Burkitt’s Homo sapiens, human Suspension
Back to top